|
NHLRC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.979200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.995400E-01 |
| Normal-vs-Stage2 |
5.944200E-01 |
| Normal-vs-Stage3 |
4.840200E-01 |
| Normal-vs-Stage4 |
4.727200E-01 |
| Stage1-vs-Stage2 |
1.690970E-01 |
| Stage1-vs-Stage3 |
9.893400E-01 |
| Stage1-vs-Stage4 |
9.371200E-01 |
| Stage2-vs-Stage3 |
2.487800E-01 |
| Stage2-vs-Stage4 |
2.567000E-01 |
| Stage3-vs-Stage4 |
9.412600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.899400E-01 |
| Normal-vs-AfricanAmerican |
7.147400E-01 |
| Normal-vs-Asian |
1.241430E-01 |
| Caucasian-vs-AfricanAmerican |
2.295400E-01 |
| Caucasian-vs-Asian |
2.868800E-01 |
| AfricanAmerican-vs-Asian |
1.019640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.397400E-01 |
| Normal-vs-Female |
7.292200E-01 |
| Male-vs-Female |
2.830400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.963600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.896600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.716400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.956400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.746800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.849000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.699400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.196000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.101830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.951780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.759200E-01 |
| Normal-vs-Grade 2 |
7.454600E-01 |
| Normal-vs-Grade 3 |
1.519950E-01 |
| Normal-vs-Grade 4 |
7.597800E-01 |
| Grade 1-vs-Grade 2 |
7.558200E-01 |
| Grade 1-vs-Grade 3 |
3.986800E-01 |
| Grade 1-vs-Grade 4 |
9.774800E-01 |
| Grade 2-vs-Grade 3 |
1.158790E-01 |
| Grade 2-vs-Grade 4 |
4.887200E-01 |
| Grade 3-vs-Grade 4 |
8.154300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.863800E-01 |
| Normal-vs-ccB subtype |
9.748800E-01 |
| ccA subtype-vs-ccB subtype |
1.930760E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.287800E-01 |
| Normal-vs-N1 |
9.176000E-01 |
| N0-vs-N1 |
7.641000E-01 |
|
|
